We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Fresh off winning a grant to develop a point-of-care diagnostic test to identify febrile diseases from a single drop of blood, Medford, N.Y.-based Chembio Diagnostics has signed an agreement with Berlin, Germany’s opTricon, a developer of mobile analysis devices for rapid diagnostic tests. Read More